Basic/Clinical Science Session
APOL1-Mediated Kidney Disease: A Blueprint for Precision Nephrology?
November 08, 2025 | 02:00 PM - 04:00 PM
Location: Room 360A, Convention Center
Session Description
Genetic discoveries have revolutionized our understanding of kidney diseases, and the discovery of APOL1 risk variants stands as a flagship breakthrough for the field. This dynamic session delves into the complex biology of APOL1-mediated kidney disease, from molecular mechanisms to clinical implications. Leading experts present cutting-edge insights into how APOL1 variants drive kidney injury, novel therapeutic strategies in development, and the broader impact on patient care. As targeted interventions become a reality, this session is a must-attend for anyone interested in the future of precision nephrology and health disparities in kidney diseases.
Learning Objective(s)
- Explain the mechanisms of APOL1-mediated kidney disease
- Assess the global epidemiology of APOL1-mediated kidney disease
- Describe the role of APOL1 genetic testing in the setting of kidney transplantation
- Summarize the latest treatments targeting APOL1-mediated kidney disease
Learning Pathway(s)
- Genetic Diseases and Development
Moderators
Presentations
- Mechanisms of APOL1-Mediated Kidney Disease
02:00 PM - 02:30 PM
- APOL1 in West Africa: Updates from the H3Africa Study
02:30 PM - 03:00 PM
- APOL1 and Kidney Transplantation: Impact on Donors and Recipients
03:00 PM - 03:30 PM
- Therapeutic Targeting of APOL1-Mediated Kidney Disease
03:30 PM - 04:00 PM